FDA
approval
· 2023-08-08
FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Teva Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for levothyroxine sodium from Teva Pharmaceuticals under ANDA 207588. This represents a routine update to an existin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)